{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:07:43Z","timestamp":1778861263992,"version":"3.51.4"},"reference-count":60,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["301624\/2022-4"],"award-info":[{"award-number":["301624\/2022-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"abstract":"<jats:p>ABSTRACT Human T-lymphotropic virus type 1 (HTLV-1) infects approximately five to 10 million individuals worldwide, although only a minority develop severe outcomes such as adult T-cell leukemia\/lymphoma (ATLL) or HTLV-1-associated myelopathy (HAM). Proviral load (PVL), while widely used, shows limited sensitivity and specificity, reinforcing the need for complementary biomarkers. Omics-based approaches have emerged as promising tools to improve risk prediction. We conducted a systematic review following PRISMA guidelines, searching PubMed, Web of Science, Virtual Health Library (BVS), and CAPES Periodicals databases for studies published between May 2020 and May 2025. Eligible studies included original observational designs investigating genomic, proteomic, and metabolic biomarkers associated with progression to ATLL or HAM. Methodological quality was assessed using tools from the National Heart, Lung, and Blood Institute (NHLBI). In total, 35 studies met the inclusion criteria, most conducted in Brazil, Japan, and Iran. A total of 67 biomarkers were identified: 37 genomic, 27 proteomic, and three metabolic with potential clinical applications in risk stratification, prognosis, and therapeutic monitoring of HTLV-1 infection. PVL remained the most frequently investigated marker but lacked predictive power in isolation. Additional candidates with strong potential included IFN-\u03b3, CXCL10, Neopterin, AnxA1, and sTNFR2. This review highlights the potential of integrated multiparametric panels\u2014combining PVL with omics-derived biomarkers\u2014as a promising strategy to improve risk stratification, prognosis, and therapeutic monitoring in people living with HTLV-1 (PLHTLV-1). However, further longitudinal and clinically validated studies are needed to confirm their applicability and support their translation into early intervention strategies, particularly during the asymptomatic phase.<\/jats:p>","DOI":"10.1590\/s1678-9946202668030","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:11:40Z","timestamp":1778857900000},"source":"Crossref","is-referenced-by-count":0,"title":["Molecular biomarkers associated with ATLL and HAM progression in HTLV-1 infection: a systematic review"],"prefix":"10.1590","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7863-2896","authenticated-orcid":false,"given":"Theo","family":"Leite","sequence":"first","affiliation":[{"name":"Universidade Municipal de S\u00e3o Caetano do Sul,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9670-6957","authenticated-orcid":false,"given":"Marcos Eduardo Souza","family":"Abreu","sequence":"additional","affiliation":[{"name":"Universidade Municipal de S\u00e3o Caetano do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6400-5201","authenticated-orcid":false,"given":"Alex Ap. Rosini","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Municipal de S\u00e3o Caetano do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3881-5840","authenticated-orcid":false,"given":"Rubens de Assis Santos","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[{"name":"Universidade Municipal de S\u00e3o Caetano do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0989-4401","authenticated-orcid":false,"given":"Lucas Araujo","family":"Rom\u00e3o","sequence":"additional","affiliation":[{"name":"Universidade Municipal de S\u00e3o Caetano do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4553-2559","authenticated-orcid":false,"given":"Jorge","family":"Casseb","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0993-4523","authenticated-orcid":false,"given":"Tatiane","family":"Assone","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-3765","authenticated-orcid":false,"given":"Fabio Eudes","family":"Leal","sequence":"additional","affiliation":[{"name":"Universidade Municipal de S\u00e3o Caetano do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5416-2724","authenticated-orcid":false,"given":"Sheila de Oliveira Garcia","family":"Mateos","sequence":"additional","affiliation":[{"name":"Universidade Municipal de S\u00e3o Caetano do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"15525","DOI":"10.1073\/pnas.1521629112","article-title":"The discovery of HTLV-1, the first pathogenic human retrovirus","volume":"112","author":"Coffin JM","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00078-21","article-title":"Clinical and public health implications of human T-lymphotropic virus type 1 infection","volume":"35","author":"Legrand N","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain A","year":"2012","journal-title":"Front Microbiol"},{"key":"ref4","article-title":"The past, present, and future of a human T-cell leukemia virus type 1 vaccine","volume":"13","author":"Tu JJ","year":"2022","journal-title":"Front Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2022.105337","article-title":"Coevolution of HTLV-1-HBZ, tax, and proviral load with host IRF-1 and CCNA-2 in HAM\/TSP patients","volume":"103","author":"Saffari M","year":"2022","journal-title":"Infect Genet Evol"},{"key":"ref6","first-page":"485","article-title":"HTLV-1 infection: an emerging risk: pathogenesis, epidemiology, diagnosis and associated diseases","volume":"32","author":"Eusebio-Ponce E","year":"2019","journal-title":"Rev Esp Quimioter"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001408","article-title":"Evaluation of antioxidant status and oxidative stress markers in HTLV-1 infected individuals: correlation with the severity of virus-induced complications","volume":"71","author":"Yaghoubi N","year":"2022","journal-title":"J Med Microbiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcancer.2013.11.003","article-title":"HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection","volume":"26","author":"Bangham CR","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13365-020-00924-2","article-title":"Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR","volume":"28","author":"Rodrigues ES","year":"2022","journal-title":"J Neurovirol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s13365-022-01088-x","article-title":"Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers","volume":"28","author":"Harding D","year":"2022","journal-title":"J Neurovirol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jmv.23227","article-title":"Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy\/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease","volume":"84","author":"Furtado MS","year":"2012","journal-title":"J Med Virol"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02507-24","article-title":"Virus-host immune interaction in asymptomatic HTLV-1 carriers","volume":"13","author":"Asigbee TW","year":"2025","journal-title":"Microbiol Spectr"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100561","article-title":"Multi-omics profiling for health","volume":"22","author":"Babu M","year":"2023","journal-title":"Mol Cell Proteomics"},{"key":"ref14","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","journal-title":"BMJ"},{"key":"ref15","series-title":"Study quality assessment tools"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02658-w","article-title":"Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation","volume":"19","author":"Assone T","year":"2022","journal-title":"J Neuroinflammation"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1416476","article-title":"IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1","volume":"15","author":"Assone T","year":"2024","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2230015","article-title":"Identification of miRnas with possible prognostic roles for HAM\/TSP","volume":"14","author":"Souza DR","year":"2023","journal-title":"Virulence"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jha2.725","article-title":"HTLV-1 cell-free DNA in plasma as a potential biomarker in HTLV-1 carriers and adult T-cell leukemia-lymphoma","volume":"4","author":"Katsuya H","year":"2023","journal-title":"EJHaem"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-05917-y","article-title":"Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM\/TSP","volume":"21","author":"Santana BB","year":"2021","journal-title":"BMC Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/bloodadvances.2019001429","article-title":"Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL","volume":"4","author":"Guerrero CL","year":"2020","journal-title":"Blood Adv"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.737941","article-title":"Following the clues: usefulness of biomarkers of neuroinflammation and neurodegeneration in the investigation of HTLV-1-associated myelopathy progression","volume":"12","author":"Souza FS","year":"2021","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.3390\/v14040751","article-title":"Elevation of the plasma levels of TNF receptor 2 in association with those of CD25, OX40, and IL-10 and HTLV-1 proviral load in acute adult T-cell leukemia","volume":"14","author":"Kato M","year":"2022","journal-title":"Viruses"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3324\/haematol.2019.234096","article-title":"Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia\/lymphoma","volume":"106","author":"Nakahata S","year":"2021","journal-title":"Haematologica"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s13365-020-00838-z","article-title":"Expression of TSLC1 in patients with HAM\/TSP","volume":"26","author":"Takenouchi N","year":"2020","journal-title":"J Neurovirol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cas.15997","article-title":"Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma","volume":"115","author":"Yamada A","year":"2024","journal-title":"Cancer Sci"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1150285","article-title":"Detection of HTLV-1 proviral DNA in cell-free DNA: potential for non-invasive monitoring of Adult T cell leukaemia\/lymphoma using liquid biopsy?","volume":"14","author":"Joris T","year":"2023","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hon.2768","article-title":"Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPa in adult T-cell leukemia\/lymphoma","volume":"38","author":"Yanagida E","year":"2020","journal-title":"Hematol Oncol"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199237","article-title":"Illuminating (HTLV-1)-induced adult T-cell leukemia\/lymphoma transcriptomic signature: a systems virology approach","volume":"338","author":"Forghani-Ramandi MM","year":"2023","journal-title":"Virus Res"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-021-00390-3","article-title":"Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK\/JNK signal transduction pathway in Adult T-cell leukemia\/lymphoma","volume":"16","author":"Shadabi S","year":"2021","journal-title":"Infect Agent Cancer"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-023-00492-0","article-title":"Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia\/lymphoma using WGCNA followed by RT-qPCR test of hub genes","volume":"18","author":"Shayeghpour A","year":"2023","journal-title":"Infect Agent Cancer"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.198875","article-title":"Signaling factors potentially associated to the pathogenesis of adult T-cell leukemia \/lymphoma: a network-analysis and novel findings assessment","volume":"319","author":"Mozhgani SH","year":"2022","journal-title":"Virus Res"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.3390\/v17010089","article-title":"CXCL-10 in cerebrospinal fluid detects neuroinflammation in HTLV-1-associated myelopathy with high accuracy","volume":"17","author":"Silva SJ","year":"2025","journal-title":"Viruses"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.3390\/v14102146","article-title":"Lessons from the cerebrospinal fluid analysis of HTLV-1-infected individuals: biomarkers of inflammation for HAM\/TSP development","volume":"14","author":"Freitas NL","year":"2022","journal-title":"viruses"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001090","article-title":"Neurofilament light in CSF and plasma is a marker of neuronal damage in HTLV-1-associated myelopathy and correlates with neuroinflammation","volume":"8","author":"Rosadas C","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jnnp-2019-321955","article-title":"Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy\/tropical spastic paraparesis treated with steroids","volume":"91","author":"Yamauchi J","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002479","article-title":"CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"7","author":"Sato T","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000371766","article-title":"High IFN-?\/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis development","volume":"58","author":"Esp\u00edndola OM","year":"2015","journal-title":"Intervirology"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis","volume":"3","author":"Yamano Y","year":"2012","journal-title":"Front Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/aid.2018.0290","article-title":"Interferon-? secretion enzyme-linked immunospot assay determined among human T cell lymphotropic virus type 1-infected subjects: a potential laboratory marker for early HTLV-1-associated myelopathy\/tropical spastic paraparesis diagnosis","volume":"36","author":"Apoliano CF","year":"2020","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/CPJ.0000000000000866","article-title":"Prognosis markers for monitoring HTLV-1 neurologic disease","volume":"11","author":"Prates G","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00126334-200105010-00001","article-title":"Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors:","volume":"27","author":"Carvalho EM","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/376529","article-title":"Majority of interferon-?-producing CD4 + cells in patients infected with human T cell lymphotrophic virus do not express tax protein","volume":"188","author":"Mitre E","year":"2003","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.5812\/jjm-132348","article-title":"High expression of inflammatory cytokines and chemokines in human T-lymphotropic virus 1-associated adult T-cell leukemia\/lymphoma","volume":"15","author":"Soltani S","year":"2022","journal-title":"Jundishapur J Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.949516","article-title":"Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) progression","volume":"13","author":"Gomes YC","year":"2022","journal-title":"Front Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00430-023-00770-z","article-title":"Pentraxin 3, a serum biomarker in human T-cell lymphotropic virus type-1-associated myelopathy patients and asymptomatic carriers","volume":"212","author":"Manzarinejad M","year":"2023","journal-title":"Med Microbiol Immunol"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105962","article-title":"XCL1, a serum biomarker in neurological diseases; HTLV-1-associated myelopathy and multiple sclerosis","volume":"174","author":"Saeidi M","year":"2023","journal-title":"Microb Pathog"},{"key":"ref48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2004199118","article-title":"Genome wide association study of HTLV-1-associated myelopathy\/tropical spastic paraparesis in the Japanese population","volume":"118","author":"Penova M","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-020-00536-y","article-title":"HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in patients living in Argentina","volume":"17","author":"Benencio P","year":"2020","journal-title":"Retrovirology"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25136858","article-title":"HLA-A*24 increases the risk of HTLV-1-associated myelopathy despite reducing HTLV-1 proviral load","volume":"25","author":"Tanaka M","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-020-00343-2","article-title":"Global expression of noncoding RNome reveals dysregulation of small RNAs in patients with HTLV-1-associated adult T-cell leukemia: a pilot study","volume":"16","author":"Nascimento A","year":"2021","journal-title":"Infect Agent Cancer"},{"key":"ref52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247713","article-title":"Deciphering microRNA-mRNA regulatory network in adult T-cell leukemia\/lymphoma; the battle between oncogenes and anti-oncogenes","volume":"16","author":"Ghobadi MZ","year":"2021","journal-title":"PloS One"},{"key":"ref53","article-title":"Genetic association of inflammatory marker GlycA with lung function and respiratory diseases","volume":"15","author":"Guo Y","year":"2024","journal-title":"Nat Commun"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4149\/av_2015_02_199","article-title":"Serum total antioxidant capacity status of HTLV-1 infected patients","volume":"59","author":"Shomali S","year":"2015","journal-title":"Acta Virol"},{"key":"ref55","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8910396","article-title":"Oxidative stress during HIV infection: mechanisms and consequences","volume":"2016","author":"Ivanov AV","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"ref56","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013901","article-title":"Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress","volume":"13","author":"Shytaj IL","year":"2021","journal-title":"EMBO Mol Med"},{"key":"ref57","first-page":"75","article-title":"Metabol\u00f4mica: defini\u00e7\u00f5es, estado-da-arte e aplica\u00e7\u00f5es representativas","volume":"41","author":"Canuto GA","year":"2018","journal-title":"Quim Nova"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya H","year":"2015","journal-title":"Blood"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/clinchem\/hvab184","article-title":"Metabolomics in clinical practice: improving diagnosis and informing management","volume":"67","author":"Odom JD","year":"2021","journal-title":"Clin Chem"},{"key":"ref60","first-page":"22","article-title":"Metabolic profile analysis in hematological malignancies","volume":"55","author":"Halicki P","year":"2024","journal-title":"Acta Haematol Pol"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652026000100604&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:11:50Z","timestamp":1778857910000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652026000100604&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":60,"alternative-id":["S0036-46652026000100604"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202668030","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e30"}}